About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in San Francisco | 5,200 Studies Near You

Clinical TrialsSan Francisco

Clinical Trials in San Francisco

Discover 5,200 clinical trials near San Francisco, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 5,200 trials

TerminatedA Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label ExtensionThis study will evaluate the efficacy, safety, and pharmacokinetics of 10 mg of oral administration balovaptan once a day (QD) compared with matching placebo in adults (18 years…NCT03504917·Dothan, Alabama and 50 others

Find Trials by Condition in San Francisco

Breast Cancerin San Francisco Lung Cancerin San Francisco Prostate Cancerin San Francisco Colorectal Cancerin San Francisco Melanomain San Francisco Leukemiain San Francisco Lymphomain San Francisco Pancreatic Cancerin San Francisco Ovarian Cancerin San Francisco Brain Cancerin San Francisco

Data from ClinicalTrials.govTerms

CompletedEXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial HypertensionThis was a multicenter, open-label study to evaluate the dose of Orenitram® (treprostinil) Extended Release Tablets achieved at 16 weeks after a short-term course of Remodulin®…NCT03497689·Fresno, California and 10 others

TerminatedOpen-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)The purpose of this study is to provide subjects who have completed participation in a Phase 2 or Phase 3 trial of LMTM continued access to therapy and to evaluate the long-term…NCT02245568·Phoenix, Arizona and 134 others

RecruitingA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerThe primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's choice (docetaxel…NCT07213674·Goodyear, Arizona and 155 others

SuspendedInfrasensor for Early Detection of a High-grade Obstructive NSTE-ACSThe objective of this prospective, cross-sectional, multicenter pivotal trial study is to validate Infrasensor's clinical performance for the detection of high grade obstructive…NCT07464704·La Jolla, California and 5 others

CompletedA Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected MothersPRIMARY: To determine the safety of envelope recombinant proteins rgp120/HIV-1MN (Genentech) and rgp120/HIV-1SF2 (Chiron/Biocine) in infants who are of indeterminate HIV status…NCT00000774·Long Beach, California and 36 others

CompletedSpine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc HerniationThis study tests the effectiveness of different treatments for the three most commonly diagnosed lumbar (lower) spine conditions.NCT00000410·Oakland, California and 12 others

UnknownAssessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral Modafinil.NCT00265278·San Francisco, California

CompletedTypology of Adherence in Adolescents: Phase IIA number of factors influence HIV-positive adolescents' acceptance of and willingness to continue taking anti-HIV medicines.NCT00106678·Los Angeles, California and 16 others

CompletedHybrid Immunotherapy for Hemophagocytic LymphoHistiocytosisDespite good progress during the last decade, hemophagocytic lymphohistiocytosis (HLH) remains difficult to treat. Two different treatment regimens have been used successfully.NCT01104025·Phoenix, Arizona and 14 others

TerminatedTesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCCONTESSA is a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with HER2 negative, HR positive LA/MBC previously treated with a taxane in the…NCT03326674·Chandler, Arizona and 206 others

TerminatedSetting up a Blood Bank for Gene Therapy in HIV-Infected InfantsThe purpose of this study is to set up a blood bank for infants who have HIV-positive mothers.NCT00000917·La Jolla, California and 7 others

CompletedLung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersThis phase II trial studies how well durvalumab works in treating patients with stage IV squamous cell lung cancer that has come back after previous treatment.NCT02766335·Birmingham, Alabama and 992 others

Active not recruitingGDNF Gene Therapy for Parkinson's DiseaseThe objective of this Phase 1b investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to the putamen in subjects with either a recent or a…NCT04167540·Irvine, California and 2 others

Active not recruitingA Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.This is a parallel, Phase 3, two-arm study for the treatment of newly diagnosed moderate or severe chronic GVHD.NCT06143891·Little Rock, Arkansas and 150 others

WithdrawnVactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint InhibitionThis is Phase 2, open label, non randomized single arm study to determine whether the administration of vactosertib with durvalumab will provide meaningful increases in the…NCT04064190·San Francisco, California and 1 other

TerminatedThe Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot TrialThis is a phase IV, multi-center, double-blind, randomized, placebo- controlled study evaluating the effect of alirocumab on SVG atherosclerotic disease burden, as assessed by…NCT03542110·San Francisco, California and 3 others

CompletedComparison of CorWatch With Right Heart Catheter Measurements in Heart FailureThis is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects.NCT04928326·San Francisco, California

CompletedA Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous CarcinomaThis is a Phase 2 study to evaluate the clinical activity and safety of ZN-c3 (azenosertib) in adult women with recurrent or persistent uterine serous carcinoma (USC).NCT04814108·Anchorage, Alaska and 55 others

CompletedSuppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerRATIONALE: Estrogen can stimulate the growth of breast tumor cells.NCT00066690·Birmingham, Alabama and 499 others

PreviousPage 3 of 260Next

Diabetes

in San Francisco

Heart Diseasein San Francisco